BX
Price
$175.32
Change
-$0.28 (-0.16%)
Updated
Sep 26 closing price
Capitalization
136.86B
19 days until earnings call
CNS
Price
$66.41
Change
+$0.04 (+0.06%)
Updated
Sep 26 closing price
Capitalization
3.39B
18 days until earnings call
Interact to see
Advertisement

BX vs CNS

Header iconBX vs CNS Comparison
Open Charts BX vs CNSBanner chart's image
Blackstone
Price$175.32
Change-$0.28 (-0.16%)
Volume$2.05M
Capitalization136.86B
Cohen & Steers
Price$66.41
Change+$0.04 (+0.06%)
Volume$216.66K
Capitalization3.39B
BX vs CNS Comparison Chart in %
Loading...
BX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BX vs. CNS commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BX is a Buy and CNS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (BX: $175.32 vs. CNS: $66.41)
Brand notoriety: BX and CNS are both not notable
Both companies represent the Investment Managers industry
Current volume relative to the 65-day Moving Average: BX: 56% vs. CNS: 88%
Market capitalization -- BX: $136.86B vs. CNS: $3.39B
BX [@Investment Managers] is valued at $136.86B. CNS’s [@Investment Managers] market capitalization is $3.39B. The market cap for tickers in the [@Investment Managers] industry ranges from $179.08B to $0. The average market capitalization across the [@Investment Managers] industry is $7.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BX’s FA Score shows that 4 FA rating(s) are green whileCNS’s FA Score has 2 green FA rating(s).

  • BX’s FA Score: 4 green, 1 red.
  • CNS’s FA Score: 2 green, 3 red.
According to our system of comparison, BX is a better buy in the long-term than CNS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BX’s TA Score shows that 3 TA indicator(s) are bullish while CNS’s TA Score has 4 bullish TA indicator(s).

  • BX’s TA Score: 3 bullish, 5 bearish.
  • CNS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both BX and CNS are a bad buy in the short-term.

Price Growth

BX (@Investment Managers) experienced а -6.56% price change this week, while CNS (@Investment Managers) price change was -3.18% for the same time period.

The average weekly price growth across all stocks in the @Investment Managers industry was -1.95%. For the same industry, the average monthly price growth was +2.07%, and the average quarterly price growth was +39.07%.

Reported Earning Dates

BX is expected to report earnings on Oct 16, 2025.

CNS is expected to report earnings on Oct 15, 2025.

Industries' Descriptions

@Investment Managers (-1.95% weekly)

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BX($137B) has a higher market cap than CNS($3.39B). BX has higher P/E ratio than CNS: BX (47.38) vs CNS (21.08). BX YTD gains are higher at: 3.900 vs. CNS (-26.381). CNS has less debt than BX: CNS (142M) vs BX (12.9B). BX has higher revenues than CNS: BX (11.6B) vs CNS (566M).
BXCNSBX / CNS
Capitalization137B3.39B4,045%
EBITDAN/A216M-
Gain YTD3.900-26.381-15%
P/E Ratio47.3821.08225%
Revenue11.6B566M2,049%
Total CashN/A230M-
Total Debt12.9B142M9,085%
FUNDAMENTALS RATINGS
BX vs CNS: Fundamental Ratings
BX
CNS
OUTLOOK RATING
1..100
6651
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
20
Undervalued
PROFIT vs RISK RATING
1..100
2771
SMR RATING
1..100
3329
PRICE GROWTH RATING
1..100
1786
P/E GROWTH RATING
1..100
7291
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CNS's Valuation (20) in the Investment Managers industry is in the same range as BX (30). This means that CNS’s stock grew similarly to BX’s over the last 12 months.

BX's Profit vs Risk Rating (27) in the Investment Managers industry is somewhat better than the same rating for CNS (71). This means that BX’s stock grew somewhat faster than CNS’s over the last 12 months.

CNS's SMR Rating (29) in the Investment Managers industry is in the same range as BX (33). This means that CNS’s stock grew similarly to BX’s over the last 12 months.

BX's Price Growth Rating (17) in the Investment Managers industry is significantly better than the same rating for CNS (86). This means that BX’s stock grew significantly faster than CNS’s over the last 12 months.

BX's P/E Growth Rating (72) in the Investment Managers industry is in the same range as CNS (91). This means that BX’s stock grew similarly to CNS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BXCNS
RSI
ODDS (%)
Bearish Trend 3 days ago
52%
Bullish Trend 3 days ago
65%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
60%
Momentum
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
64%
MACD
ODDS (%)
Bearish Trend 3 days ago
51%
Bearish Trend 3 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
61%
Bearish Trend 3 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
68%
Advances
ODDS (%)
Bullish Trend 18 days ago
77%
Bullish Trend 18 days ago
62%
Declines
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 4 days ago
63%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
65%
Bullish Trend 3 days ago
60%
Aroon
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 3 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
BX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CNS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LILAK8.390.15
+1.82%
Liberty Latin America Ltd
OPTX1.550.01
+0.65%
Syntec Optics Holdings
HQY96.530.37
+0.38%
HealthEquity
ATMCU12.23N/A
N/A
AlphaTime Acquisition Corp
PACB1.21-0.01
-0.82%
Pacific Biosciences of California

BX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BX has been closely correlated with KKR. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if BX jumps, then KKR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BX
1D Price
Change %
BX100%
-0.16%
KKR - BX
86%
Closely correlated
-1.22%
CG - BX
84%
Closely correlated
+0.53%
JHG - BX
82%
Closely correlated
+0.97%
BN - BX
81%
Closely correlated
-0.06%
OWL - BX
81%
Closely correlated
+2.30%
More

CNS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNS has been closely correlated with APAM. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if CNS jumps, then APAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNS
1D Price
Change %
CNS100%
+0.06%
APAM - CNS
75%
Closely correlated
+0.21%
BX - CNS
70%
Closely correlated
-0.16%
TROW - CNS
69%
Closely correlated
+0.25%
VRTS - CNS
68%
Closely correlated
+1.22%
BEN - CNS
64%
Loosely correlated
-0.56%
More